Gregory Flesher
Chief Executive Officer bei RENEO PHARMACEUTICALS, INC.
Vermögen: 25 232 $ am 31.03.2024
Profil
Gregory J.
Flesher is currently the President, Chief Executive Officer & Director at Reneo Pharmaceuticals, Inc. and Reneo Pharma Ltd.
He previously served as the Chief Executive Officer & Director at Otic Pharma Ltd.
from 2015 to 2017, Eledon Pharmaceuticals, Inc. from 2017 to 2020, and Avanir Pharmaceuticals, Inc. from 2006 to 2015.
Additionally, he held the position of Director-Hepatology Sales & Pulmonary Marketing at InterMune, Inc. from 2002 to 2006.
Mr. Flesher also worked as a Director at Adynxx, Inc. from 2019 to 2021.
He obtained his undergraduate degree from Purdue University and The Indiana University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.03.2023 | 15 200 ( 0,05% ) | 25 232 $ | 31.03.2024 |
Aktive Positionen von Gregory Flesher
| Unternehmen | Position | Beginn |
|---|---|---|
| RENEO PHARMACEUTICALS, INC. | Chief Executive Officer | 09.12.2020 |
| Reneo Pharma Ltd. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Gregory Flesher
| Unternehmen | Position | Ende |
|---|---|---|
| ADYNXX, INC. | Director/Board Member | 01.06.2021 |
| ELEDON PHARMACEUTICALS, INC. | Chief Executive Officer | 04.09.2020 |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Chief Executive Officer | 01.05.2017 |
| AVANIR PHARMACEUTICALS INC | Corporate Officer/Principal | 01.01.2015 |
| INTERMUNE INC | Sales & Marketing | 01.01.2006 |
Ausbildung von Gregory Flesher
| Purdue University | Undergraduate Degree |
| The Indiana University School of Medicine | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| RENEO PHARMACEUTICALS, INC. | Health Technology |
| ELEDON PHARMACEUTICALS, INC. | Health Technology |
| ADYNXX, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Otic Pharma Ltd.
Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Health Technology |
| Reneo Pharma Ltd. |
